IL1B and metabolic dysfunction-associated steatotic liver disease: In addition, NAFLD supplemented with the MI displayed a significant down-regulation in inflammation-related genes Tnfα and Il-1β expression levels when compared to their NAFLD counterparts, suggesting MI treatment influences the regulatory crosstalk between the immune system and the intestinal barrier function preserving intestinal permeability.